Nutritional parameters and outcomes in patients admitted to intensive care with COVID-19: a retrospective single-centre service evaluation
Dr Timothy Eden, Shane Mcauliffe, Dominic Crocombe, Jonathan Neville, Sumantra Ray
BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000270
D deficiency may also associate with poorer outcomes and mortality, supporting a possible role of vitamin D in immune function specific to pulmonary inflammation and COVID-19 pathophysiology. There are plausible associations between raised BMI, glycaemic control, vitamin D status and poor prognosis, as seen in wider studies; however, in this service evaluation audit during the first wave of the pandemic in the UK, with a limited data set available for this analysis, the associations did not reach statistical significance. Further research is needed into specific nutritional markers influencing critical care admissions with COVID-19. ► This snapshot audit in a London ICU from the first peak of the COVID-19 pandemic adds to the body of evidence associating overweight/obesity as a risk factor of disease severity and mortality in COVID-19. ► Further data suggesting baseline vitamin D status may influence severity of COVID-19 as higher mortality was observed in individuals with vitamin D deficiency (<25 nmol/L). ► This highlights baseline nutritional parameters that are easily obtainable in the critical care setting and suggests additional nutritional markers worthy of further research.
Contributors TE, JN and SR planned the above service evaluation and determined the data collection. TE and JN collected the relevant data and JN and SR provided the statistical analysis. TE, SM and DC contributed to the report writing and discussion of this service evaluation. SR supervised the undertaking of the work and contributed to the overall revisions prior to submission by TE.
Competing interests None declared. Patient consent for publication Not required. Provenance and peer review Not commissioned; externally peer reviewed by Marcello Scopazzini, NHS Lothian, Edinburgh, UK. Data availability statement All data relevant to the study are included in the article or uploaded as supplemental information. All relevant data and statistical analyses have been included within the submission. For further information and additional data, please contact the first author Timothy Eden ( timothy. eden@ nhs. net). Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology,..
References
Amrein, Papinutti, Mathew, Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa, Endocr Connect,
doi:10.1530/EC-18-0184Apicella, Campopiano, Mantuano, COVID-19 in people with diabetes: understanding the reasons for worse outcomes, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30238-2Barazzoni, Bischoff, Breda, ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection, Clin Nutr,
doi:10.1016/j.clnu.2020.03.022Barron, Bakhai, Kar, Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a wholepopulation study, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30272-2Berger, Nutrition and micronutrient therapy in critical illness should be individualized, JPEN J Parenter Enteral Nutr,
doi:10.1002/jpen.2002Carpagnano, Lecce, Quaranta, Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest,
doi:10.1007/s40618-020-01370-xCastillo, Costa, Barrios, Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol,
doi:10.1016/j.jsbmb.2020.105751De, Vega, Barquin, Boros, Could attitudes toward COVID-19 in Spain render men more vulnerable than women?
Faniyi, Lugg, Faustini, Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic, medRxiv,
doi:10.1101/2020.10.05.20206706Finucane, Davenport, Coronavirus, Coronavirus and obesity: could insulin resistance mediate the severity of Covid-19 infection?, Front Public Health,
doi:10.3389/fpubh.2020.00184Griffin, Wall, Blake, Vitamin D status of adults in the community, in outpatient clinics, in hospital, and in nursing homes in the West of Ireland, Journals Gerontol Ser A
Griffith, Sharma, Holliday, Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions, Prev Chronic Dis,
doi:10.5888/pcd17.200247Hansdottir, Monick, Hinde, Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense, J Immunol,
doi:10.4049/jimmunol.181.10.7090Hogue, Stearns, Colantuoni, The impact of obesity on outcomes after critical illness: a meta-analysis, Intensive Care Med,
doi:10.1007/s00134-009-1424-5Jong, Jung, Chanques, Obesity and mortality in critically ill patients: another case of the Simpson paradox?, Chest,
doi:10.1378/chest.11-3302Jong, Molinari, Sebbane, Feasibility and effectiveness of prone position in morbidly obese patients with ARDS: a case-control clinical study, Chest,
doi:10.1378/chest.12-2115Lemyze, Courageux, Maladobry, Implications of obesity for the management of severe coronavirus disease 2019 pneumonia, Crit Care Med,
doi:10.1097/CCM.0000000000004455Martineau, Jolliffe, Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ,
doi:10.1136/bmj.i6583Munshi, Hussein, Toraih, Vitamin D insufficiency as a potential culprit in critical COVID-19 patients, J Med Virol,
doi:10.1002/jmv.26360Murad, Coburn, Coto-Yglesias, Glycemic control in non-critically ill hospitalized patients: a systematic review and metaanalysis, J Clin Endocrinol Metab,
doi:10.1210/jc.2011-2100Nair, Venkatesh, Center, Vitamin D deficiency and supplementation in critical illness-the known knowns and known unknowns, Crit Care,
doi:10.1186/s13054-018-2185-8Peckham, De Gruijter, Raine, Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission, Nat Commun,
doi:10.1038/s41467-020-19741-6Peng, Meng, Guan, Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV
Pugach, Pugach, Strong correlation between prevalence of severe vitamin D deficiency and population mortality rate from COVID-19 in Europe, Wien Klin Wochenschr,
doi:10.1007/s00508-021-01833-ySama, Ravera, Santema, Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors, Eur Heart J,
doi:10.1093/eurheartj/ehaa373Simonnet, Chetboun, Poissy, High prevalence of obesity in severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation, Obesity,
doi:10.1002/oby.22831Steele, Finucane, Griffin, Obesity is associated with altered lung function independently of physical activity and fitness, Obesity,
doi:10.1038/oby.2008.584Vimaleswaran, Berry, Lu, Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts, PLoS Med,
doi:10.1371/journal.pmed.1001383Whittle, Molinger, Macleod, Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19, Crit Care,
doi:10.1186/s13054-020-03286-7Zhu, She, Cheng, Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes, Cell Metab,
doi:10.1016/j.cmet.2020.04.021
